PRESS RELEASE: Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

PRESS RELEASE   THE DARK REPORT 21806 Briarcliff Dr. Spicewood, Texas 78669 512-264-7103 o 512-264-0969 f   FOR IMMEDIATE RELEASE   Media Contact: Chris Garcia chris@darkreport.com   AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance, and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk...

New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

PRESS RELEASE THE DARK REPORT 21806 Briarcliff Dr. Spicewood, Texas 78669 512-264-7103 o 512-264-0969  f FOR IMMEDIATE RELEASE Media Contact: Chris Garcia Chris@darkreport.com AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets. “The secret is to offer...

Even as Digital Pathology Is Poised to Be Disruptive in Primary Diagnosis, Most Anatomic Pathology Groups Are Unprepared for How Their Incomes Will Change

Pathologists and practice administrators should prepare a strategy and a timetable for their group’s acquisition and deployment of a digital pathology system and whole slide imaging Anatomic pathology is a medical specialty at the brink of a major technological disruption. FDA clearance of the first digital pathology system and whole slide imaging (WSI) for primary diagnosis means that every surgical pathologist will soon need to decide when to adopt this technology to avoid declines in group...

Coming PAMA Price Cuts to Medicare Clinical Lab Fees Expected to Be Heavy Financial Blow to Hospital Laboratory Outreach Programs

All hospital labs need to understand the negative financial impact to their labs and have a plan to absorb the fee cuts and remain clinically and financially viable If you believe some experts, in just 13 months many of the nation’s hospital medical laboratory outreach programs will experience a financial disaster that could put them out of business and reduce Medicare patients’ access to lab testing services. This event happens on January 1, 2018, when Medicare officials implement substantial...

How Smart Clinical Laboratories and Genetic Testing Labs Are Collecting More Revenue by Pricing Tests to Meet the Expectations of Patients

By rethinking how their medical labs relate to health insurers, physicians, and patients, a handful of progressive lab companies are enjoying increased revenue while also lifting patient and payer satisfaction There is widespread agreement across the clinical laboratory industry that it is becoming ever more difficult to have health plans reimburse claims for common tests, molecular assays, and genetic tests in a reliable and consistent manner. Many lab companies report that they are...